Presentation TCT 2014 TCT 252: Preprocedural Statin Administration Benefit According to Baseline Renal Function: A Meta-analysis of Randomized Controlled Trials Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Daniele Giacoppo, MD September 13, 2014
Presentation TCT 2014 Meta-analysis: From PRISMA Standards to Utility in Guiding Practice Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Sripal Bangalore September 13, 2014
Presentation TCT 2014 Definition, Reliability, and Interpretation of Surrogate Endpoints Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen September 13, 2014
Presentation TCT 2014 Subgroup Analyses: Proceed (and Interpret) with Caution Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Eugene H. Blackstone September 13, 2014
Presentation TCT 2014 Randomized vs Observational Studies: Strengths and Weaknesses Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen September 13, 2014
Presentation TCT 2014 CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke September 13, 2014
Presentation TCT 2014 US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds September 13, 2014
Presentation TCT 2014 PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia September 13, 2014
Presentation Cost-Effectiveness of PCI with DES vs Bypass Surgery for Patients with 3-Vessel or Left Main CAD Presenter: David J. Cohen August 11, 2014
Presentation TVT 2014 The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies Presenter: David J. Cohen June 07, 2014
Presentation Fellows 2014 Essentials of Clinical Trial Design: Statistics 101 for the Interventionalist Presenter: David Cohen April 12, 2014
Presentation TCT 2013 A Critical Analysis of Functional Improvement after TAVR in the CoreValve US Extreme Risk Study Presenter: David Cohen October 29, 2013
Presentation TCT 2013 Stop the Debate! Selective Use of BMS Is Rational and Cost-Effective Presenter: David Cohen October 28, 2013
Presentation TCT 2013 Transradial Intervention in STEMI: How Long Can We Delay Door-to-Balloon Time? Presenter: David Cohen October 28, 2013
Presentation TCT 2013 SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona... Presenter: David Cohen October 28, 2013
Presentation TCT 2013 A Synthesis of the Global Literature on TAVR Cost-effectiveness Presenter: David Cohen October 28, 2013
Presentation TVT 2013 Can We Afford TAVR? Impact on US Hospitals and Health Systems: Lessons from PARTNER and Beyond Presenter: David Cohen June 13, 2013
Presentation TVT 2013 TAVR Cost-effectiveness and Reimbursement: A Global Gordian Knot Presenter: David Cohen June 12, 2013
Presentation TCTAP 2013 Can We Afford TAVR? Economic Insights from the PARTNER Trial Presenter: David J. Cohen April 25, 2013